Lexeo Therapeutics (LXEO) Research & Development (2022 - 2023)
Historic Research & Development for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to $8.2 million.
- Lexeo Therapeutics' Research & Development fell 2790.02% to $8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $53.1 million, marking a year-over-year change of. This contributed to the annual value of $74.1 million for FY2024, which is 3945.23% up from last year.
- Per Lexeo Therapeutics' latest filing, its Research & Development stood at $8.2 million for Q4 2023, which was down 2790.02% from $17.2 million recorded in Q3 2023.
- Over the past 5 years, Lexeo Therapeutics' Research & Development peaked at $17.2 million during Q3 2023, and registered a low of $8.2 million during Q4 2023.